These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 10576412

  • 1. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.
    Crivellato E, Candussio L, Rosati AM, Decorti G, Klugmann FB, Mallardi F.
    Histochem J; 1999 Oct; 31(10):635-43. PubMed ID: 10576412
    [Abstract] [Full Text] [Related]

  • 2. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 3. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
    Candussio L, Crivellato E, Rosati AM, Klugmann FB, Granzotto M, Giraldi T, Decorti G.
    Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538
    [Abstract] [Full Text] [Related]

  • 4. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A, Decorti G, Klugmann FB, Candussio L, Granzotto M, Melato M, Giraldi T.
    Anticancer Res; 2000 May; 20(5B):3403-10. PubMed ID: 11131640
    [Abstract] [Full Text] [Related]

  • 5. Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line.
    Decorti G, Peloso I, Favarin D, Klugmann FB, Candussio L, Crivellato E, Mallardi F, Baldini L.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):525-30. PubMed ID: 9655898
    [Abstract] [Full Text] [Related]

  • 6. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
    Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):148-58. PubMed ID: 17963743
    [Abstract] [Full Text] [Related]

  • 7. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K, Hirai M, Tanigawara Y, Ueda K, Takano M, Hori R, Inui K.
    Biochem Pharmacol; 1997 Mar 07; 53(5):741-6. PubMed ID: 9113094
    [Abstract] [Full Text] [Related]

  • 8. Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. Multidrug transporters in the LLC-PK(1) cell line and its resistant counterpart.
    Decorti G, Rosati A, Candussio L, Giraldi T, Bartoli Klugmann F.
    Biochem Pharmacol; 2001 Jan 01; 61(1):61-6. PubMed ID: 11137710
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
    Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF.
    J Pharmacol Exp Ther; 2000 May 01; 293(2):376-82. PubMed ID: 10773005
    [Abstract] [Full Text] [Related]

  • 13. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Biol Pharm Bull; 1999 Dec 01; 22(12):1355-9. PubMed ID: 10746169
    [Abstract] [Full Text] [Related]

  • 14. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
    Brimer C, Dalton JT, Zhu Z, Schuetz J, Yasuda K, Vanin E, Relling MV, Lu Y, Schuetz EG.
    Pharm Res; 2000 Jul 01; 17(7):803-10. PubMed ID: 10990198
    [Abstract] [Full Text] [Related]

  • 15. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T, Kimura O, Sakata M.
    Toxicol Appl Pharmacol; 2002 Dec 15; 185(3):166-71. PubMed ID: 12498733
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
    Dudley AJ, Brown CD.
    Br J Pharmacol; 1996 Mar 15; 117(6):1139-44. PubMed ID: 8882608
    [Abstract] [Full Text] [Related]

  • 20. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H.
    Biol Pharm Bull; 2009 Sep 15; 32(9):1588-93. PubMed ID: 19721237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.